IDEXX Laboratories Inc
NASDAQ:IDXX
Relative Value
The Relative Value of one IDXX stock under the Base Case scenario is 320.7 USD. Compared to the current market price of 477.9 USD, IDEXX Laboratories Inc is Overvalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
IDXX Competitors Multiples
IDEXX Laboratories Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40.1B USD | 10.6 | 45.7 | 32.9 | 36.4 | ||
US |
Abbott Laboratories
NYSE:ABT
|
182.5B USD | 4.5 | 32.5 | 19.1 | 28.5 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.3B USD | 18.5 | 68.1 | 55.8 | 70 | ||
US |
Stryker Corp
NYSE:SYK
|
125.6B USD | 6 | 37.3 | 24.3 | 29.8 | ||
IE |
Medtronic PLC
NYSE:MDT
|
108.6B USD | 3.4 | 25.9 | 13.8 | 19.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
107.6B USD | 7.3 | 60.9 | 30.6 | 45.3 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 3.5 | 55.6 | 18.6 | 39.3 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.1B EUR | 2.7 | 38.3 | 18.4 | 31 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.4B USD | 8.4 | 36.4 | 26.4 | 28.6 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
51.4B USD | 13.5 | 80.3 | 60.1 | 78.2 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.6B CNY | 10.7 | 32.5 | 28.3 | 28.3 |